Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Antimicrobial peptides (AMPs) are diverse, short, mostly cationic peptides produced by a wide variety of organisms as a crucial part of the innate immune system. They display broad-spectrum antimicrobial activity against bacteria (both Gram-positive and Gram-negative), fungi, viruses, and even cancerous or transformed cells. AMPs kill pathogens primarily by destabilizing microbial membranes through a range of biophysical mechanisms but can also target intracellular processes such as nucleic acid and protein synthesis. In addition, many AMPs modulate the immune response, promote wound healing, and have anti-inflammatory or antitumor effects. Unlike a classical therapeutic target (receptor, enzyme, etc.), AMPs are effector molecules or drug classes themselves; thus, "antimicrobial peptide activity" refers to the overall function, not a specific druggable molecule.
Disruption of microbial cell membranes (barrel-stave, toroidal pore, carpet models); Inhibition of cell wall synthesis; Inhibition of DNA, RNA, and protein synthesis; Immunomodulation; Inhibition of gene expression or protein synthesis; Compaction/condensation of nucleic acids in bacteria
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Antimicrobial peptide activity (AMP).